Keyphrases
Agonism
20%
Anandamide
100%
Autoimmune Skin Disease
20%
Balb C Mice
20%
Biological Activity
20%
Cannabinoid Receptor 1 (CB1R)
20%
Clinical Effect
20%
Clinical Score
20%
Cutaneous Lupus Erythematosus
100%
Cutaneous Penetration
20%
Drug Development
20%
Drug Penetration
20%
Endocannabinoids
20%
Extended Persistence
20%
Extended Release
20%
Follicular Unit
20%
Histological Score
20%
Iba1
20%
Immunomodulatory Effect
40%
Inflammatory Cytokines
100%
Interleukin-6
20%
Keratinocytes
20%
Lesion Score
20%
Lesion Severity
100%
Lesional
20%
Lpr Mice
20%
Lupus
20%
Monocyte Chemoattractant protein-1 (MCP-1)
20%
Murine Model
100%
Nanoencapsulation
100%
Nanoparticle Encapsulation
20%
Pathological Lesions
20%
Prophylactic Application
20%
Systemic Lupus Erythematosus
20%
Therapeutic Potential
20%
Topical Treatment
20%
Treatment Effect
20%
Treatment Efficacy
20%
Twice Daily
20%
Ultraviolet-B (UV-B)
20%
Pharmacology, Toxicology and Pharmaceutical Science
Anandamide
100%
Autoimmune Skin Disease
20%
Bagg Albino Mouse
20%
Base
20%
Biological Activity
20%
Cannabinoid Receptor
20%
Combination Therapy
20%
Cytokine
100%
Drug Development
20%
Endocannabinoid
20%
Murphy Roths Large Lymphoproliferative Mouse
20%
Nanoparticle
20%
Skin Lupus Erythematosus
100%
Systemic Lupus Erythematosus
20%